Breaking News Instant updates and real-time market news.

GLMD

Galmed

$12.75

0.07 (0.55%)

07:37
07/13/18
07/13
07:37
07/13/18
07:37

Technical Take: Galmed moves higher, analyst action

The shares are moving up over 8.4% to $13.85 in the pre-market, adding to the over 21% gain yesterday. At current price next resistance is at $14.90. Support is at $13.38. As previously reported, Stifel initiated coverage at Buy with a $35 price target.

GLMD Galmed
$12.75

0.07 (0.55%)

07/13/18
STFL
07/13/18
INITIATION
Target $35
STFL
Buy
Galmed initiated with a Buy at Stifel
Stifel analyst Adam Walsh initiated Galmed with a Buy rating and $35 price target, calling it a "legitimate late-stage NASH play" after Aramchol recently proved itself in a Phase 2 trial as a clearly active and "very safe" compound for treating NASH.
07/12/18
07/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Galmed (GLMD) initiated with an Overweight at Cantor Fitzgerald. 2. VF Corp. (VFC) initiated with a Buy at Deutsche Bank. 3. NetApp (NTAP) initiated with a Buy at Guggenheim. 4. Rayonier Advanced Materials (RYAM) initiated with a Buy at Berenberg. 5. Ebix (EBIX) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/18
CANT
07/12/18
INITIATION
Target $59
CANT
Overweight
Cantor puts $59 price target on 'undervalued' NASH play Galmed
Cantor Fitzgerald analyst Elemer Piros last night initiated coverage of Galmed Pharmaceuticals (GLMD) with an Overweight rating and $59 price target. The stock closed yesterday down 45c to $10.55. The company is developing Aramchol, a novel, once-daily, oral therapy to treat liver diseases using fattyacid/bile-acid conjugates, Piros tells investors in a research note. The analyst believes that by Q4 of 2019, only three meaningful non-alcoholic steatohepatitis pivotal programs will be in development: Allergan's (AGN) cenicriviroc, Madrigal Pharmaceuticals' (MDGL) MGL-3196, and Galmed's Aramchol. Of the three drugs, Galmed's has the highest likelihood of achieving improvement on NASH resolution without worsening of fibrosis, and improvement in fibrosis score without worsening of NASH, Piros argues. He believes Galmed is undervalued relative to peers in the NASH space.
07/11/18
CANT
07/11/18
INITIATION
Target $59
CANT
Overweight
Galmed initiated with an Overweight at Cantor Fitzgerald
Cantor analyst Elemer Piros initiated Galmed with an Overweight and $59 price target.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$105.97

1.31 (1.25%)

05:41
10/17/18
10/17
05:41
10/17/18
05:41
Downgrade
Lowe's rating change  »

Lowe's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

HD

Home Depot

$193.61

2.51 (1.31%)

05:40
10/17/18
10/17
05:40
10/17/18
05:40
Downgrade
Home Depot rating change  »

Home Depot downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLCA

U.S. Silica

$18.72

0.38 (2.07%)

05:40
10/17/18
10/17
05:40
10/17/18
05:40
Downgrade
U.S. Silica rating change  »

U.S. Silica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CVIA

Covia

$7.58

0.18 (2.43%)

05:39
10/17/18
10/17
05:39
10/17/18
05:39
Downgrade
Covia rating change  »

Covia downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SND

Smart Sand

$3.81

-0.07 (-1.80%)

05:39
10/17/18
10/17
05:39
10/17/18
05:39
Downgrade
Smart Sand rating change  »

Smart Sand downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$9.49

-0.16 (-1.66%)

05:38
10/17/18
10/17
05:38
10/17/18
05:38
Downgrade
Hi-Crush Partners rating change  »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

SCGLY

Societe Generale

$0.00

(0.00%)

, BNPQY

BNP Paribas

$0.00

(0.00%)

05:38
10/17/18
10/17
05:38
10/17/18
05:38
Periodicals
Societe Generale CEO pulls out of Saudi Arabia summit, Reuters reports »

Societe Generale (SCGLY)…

SCGLY

Societe Generale

$0.00

(0.00%)

BNPQY

BNP Paribas

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFRY

Safran

$0.00

(0.00%)

05:37
10/17/18
10/17
05:37
10/17/18
05:37
Downgrade
Safran rating change  »

Safran downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$0.00

(0.00%)

05:36
10/17/18
10/17
05:36
10/17/18
05:36
Periodicals
Uber, Grab fined by Philippine watchdog for rushed merger, Reuters reports »

The Philippine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVPUF

CP All

$0.00

(0.00%)

05:35
10/17/18
10/17
05:35
10/17/18
05:35
Downgrade
CP All rating change  »

CP All downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKPNY

KPN

$0.00

(0.00%)

05:33
10/17/18
10/17
05:33
10/17/18
05:33
Upgrade
KPN rating change  »

KPN upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGR

Eiger BioPharmaceuticals

$10.88

0.63 (6.15%)

05:32
10/17/18
10/17
05:32
10/17/18
05:32
Recommendations
Eiger BioPharmaceuticals analyst commentary  »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

ALTR

Altair

$35.24

1.14 (3.34%)

05:29
10/17/18
10/17
05:29
10/17/18
05:29
Hot Stocks
Altair announces acquisition of SIMSOLID »

Altair has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 15

    Nov

  • 16

    Nov

ARWR

Arrowhead

$13.86

0.71 (5.40%)

05:27
10/17/18
10/17
05:27
10/17/18
05:27
Recommendations
Arrowhead analyst commentary  »

Arrowhead 25% pullback a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

UTX

United Technologies

$132.50

2.18 (1.67%)

05:27
10/17/18
10/17
05:27
10/17/18
05:27
Recommendations
United Technologies analyst commentary  »

UTC Aerospace Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UTX

United Technologies

$132.50

2.18 (1.67%)

05:25
10/17/18
10/17
05:25
10/17/18
05:25
Hot Stocks
Royal Dutch Touring Club ANWB selects Pratt & Whitney for EMS fleet renewal »

Pratt & Whitney, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BIIB

Biogen

$338.26

9.52 (2.90%)

05:24
10/17/18
10/17
05:24
10/17/18
05:24
Hot Stocks
Biogen announces European launch of Imraldi »

Samsung Bioepis, a joint…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

NFLX

Netflix

$346.40

13.29 (3.99%)

05:23
10/17/18
10/17
05:23
10/17/18
05:23
Recommendations
Piper says Netflix is back on track, boosts price target to $430 »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

IQ

iQIYI

$25.91

-0.19 (-0.73%)

, VIA

Viacom

$36.07

1.11 (3.18%)

05:22
10/17/18
10/17
05:22
10/17/18
05:22
Hot Stocks
iQIYI signs international distribution agreement with Viacom »

iQIYI (IQ ) announced it…

IQ

iQIYI

$25.91

-0.19 (-0.73%)

VIA

Viacom

$36.07

1.11 (3.18%)

VIAB

Viacom

$32.83

1.05 (3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip

$34.48

-1.69 (-4.67%)

, AFLYY

Air France-KLM

$0.00

(0.00%)

05:21
10/17/18
10/17
05:21
10/17/18
05:21
Hot Stocks
Ctrip, KLM sign strategic partnership agreement »

Chinese Premier Li…

CTRP

Ctrip

$34.48

-1.69 (-4.67%)

AFLYY

Air France-KLM

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFY

Infosys

$10.22

0.32 (3.23%)

05:17
10/17/18
10/17
05:17
10/17/18
05:17
Recommendations
Infosys analyst commentary  »

Berenberg sees 30%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

TECH

Bio-Techne

$185.40

2.84 (1.56%)

05:13
10/17/18
10/17
05:13
10/17/18
05:13
Initiation
Bio-Techne initiated  »

Bio-Techne initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BIO

Bio-Rad

$289.60

11.73 (4.22%)

05:12
10/17/18
10/17
05:12
10/17/18
05:12
Initiation
Bio-Rad initiated  »

Bio-Rad initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

  • 07

    Nov

PSTG

Pure Storage

$23.40

1.1 (4.93%)

, NTAP

NetApp

$77.98

2.63 (3.49%)

05:10
10/17/18
10/17
05:10
10/17/18
05:10
Upgrade
Pure Storage, NetApp rating change  »

Pure Storage upgraded to…

PSTG

Pure Storage

$23.40

1.1 (4.93%)

NTAP

NetApp

$77.98

2.63 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

NTAP

NetApp

$77.98

2.63 (3.49%)

05:08
10/17/18
10/17
05:08
10/17/18
05:08
Upgrade
NetApp rating change  »

NetApp upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.